Infliximab therapy for a severe case of IgG4-related ocular adnexal disorder recalcitrant to corticosteroid treatment

Ocul Immunol Inflamm. 2012 Dec;20(6):478-80. doi: 10.3109/09273948.2012.714045. Epub 2012 Sep 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Antibodies, Monoclonal / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Resistance*
  • Glucocorticoids / therapeutic use*
  • Humans
  • Immunoglobulin G / immunology*
  • Infliximab
  • Male
  • Panuveitis / diagnosis
  • Panuveitis / drug therapy*
  • Panuveitis / immunology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Glucocorticoids
  • Immunoglobulin G
  • Tumor Necrosis Factor-alpha
  • Infliximab